Effects of health insurance and race on breast carcinoma treatments and outcomes

Cancer

Volumn 89, Issue 11, 2000, Pages 2202-2213

  Roetzheim, Richard G ^a   Gonzalez, Eduardo C ^a   Ferrante, Jeanne M ^a   Pal, Naazneen ^a   Van Durme, Daniel J ^a   Krischer, Jeffrey P ^b  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

Breast neoplasms; Ethnic groups; Florida; Health insurance; Health maintenance organizations; Managed care programs; Medicaid; Medically uninsured; Medicare; Registries

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; DEATH; FEMALE; HEALTH CARE; HEALTH INSURANCE; HEALTH MAINTENANCE ORGANIZATION; HUMAN; MAJOR CLINICAL STUDY; MEDICAID; MEDICARE; PRIORITY JOURNAL; RACE; TREATMENT OUTCOME;

AFRICAN AMERICANS; AFRICAN CONTINENTAL ANCESTRY GROUP; BREAST NEOPLASMS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FLORIDA; HISPANIC AMERICANS; HUMANS; INSURANCE, HEALTH; MASTECTOMY, SEGMENTAL; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATIENT ACCEPTANCE OF HEALTH CARE; PROPORTIONAL HAZARDS MODELS; REGISTRIES; SURVIVAL RATE;

EID: 0034548728     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0142(20001201)89:11<2202::AID-CNCR8>3.0.CO;2-L     Document Type: Article

References (77)

1. Cancer statistics, 2000
2. Adjuvant chemotherapy of breast cancer
3. Adjuvant chemotherapy for breast cancer
4. National Institutes of Health Consensus Development Conference Statement. Treatment of early-stage breast cancer
5. Treatment of early-stage breast cancer
6. Mastectomy or lumpectomy? The choice of operation for clinical stages I and II breast cancer
7. Report of the council on scientific affairs: Management of patients with node-negative breast cancer
8. Adjuvant systemic therapy for women with node-negative breast cancer
9. Adjuvant systemic therapy for women with node-positive breast cancer
10. Breast radiotherapy after breast-conserving surgery
11. Treatment differences and other prognostic factors related to breast cancer survival
12. Underutilization of breast-conserving surgery and radiation therapy among women with stage I or II breast cancer
13. Geographic variation in the use of breast-conserving treatment for breast cancer
14. Minimal increase in use of breast-conserving surgery from 1986 to 1990
15. Geographic variation in the treatment of localized breast cancer
16. Contrasts in survival of black and white cancer patients, 1960-73
17. Social class and black-white differences in breast cancer survival
18. Race and socio-economic status in survival from breast cancer
19. Racial differences in survival from breast cancer. Results of the National Cancer Institute Black/White Cancer Survival Study
20. Black/white differences in type of initial breast cancer treatment and implications for survival
21. Breast cancer: Is ethnicity an independent prognostic factor for survival?
22. The effect of managed care on quality: A review of the evidence
23. Insurance coverage of patients with breast cancer in the 1991 commission on cancer patient care evaluation study
24. Treating early-stage breast cancer: Hospital characteristics associated with breast-conserving surgery
25. The effect of insurance coverage on breast cancer patients' treatment and hospital choices
26. The relation between health insurance coverage and clinical outcomes among women with breast cancer
27. Stage at diagnosis and treatment patterns among older women with breast cancer. An HMO and fee-for-service comparison
28. Breast cancer survival and treatment in health maintenance organization and fee-for-service settings
29. Breast cancer treatment choice and mastectomy length of stay: A comparison of HMO and other privately insured women
30. The quality of care for treatment of early stage breast carcinoma: Is it consistent with national guidelines?
31. Hospital variables associated with quality of care for breast cancer patients
32. Treatment modality and quality differences for black and white breast-cancer patients treated in community hospitals
33. Socioeconomic factors and race in breast cancer recurrence and
34. Determinants of late stage diagnosis of breast and cervical cancer: The impact of age, race, social class, and hospital type
35. Stage at diagnosis in breast cancer: Race and socioeconomic factors
36. Breast cancer: Factors associated with stage at diagnosis in black and white woman
37. Use of community versus individual socioeconomic data predicting variation in hospital use
38. Overcoming the absence of socioeconomic data in medical records: Validation and application of a census-based methodology
39. Bringing context back into epidemiology: Variables and fallacies in multilevel analysis
40. Social class: The missing link in U.S. health data
41. Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer
42. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer
43. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy
44. Trends and outcomes of outpatient mastectomy in elderly women
45. The effect of comorbidity on 3-year survival of women with primary breast cancer
46. The effect of age and comorbidity in the treatment of elderly women with nonmetastatic breast cancer
47. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation
48. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases
49. Modeling and variable selection in epidemiologic analysis
50. Graphical methods for assessing violations of the proportional hazards assumption in Cox regression
51. Lumpectomy vs. mastectomy. The cost of breast preservation for cancer
52. The effects of health insurance and race-ethnicity on the early detection of cancer
53. Breast and cervical cancer screening among underserved women. Baseline survey results from six states
54. Who gets screened for cervical and breast cancer? Results from a new national survey
55. Screening mammography: A missed clinical opportunity?
56. Reverse targeting of preventive care due to lack of health insurance
57. The influence of black race and socioeconomic status on the use of breast conserving surgery for Medicare beneficiaries
58. Organizing care for patients with chronic illness
59. Managed care: Jekyll or Hyde?
60. Prognosis among African-American women and white women with lymph node negative breast carcinoma: Findings from two randomized clinical trials of the National Surgical Adjuvant Breast and Bowel Project (NSABP)
61. Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States
62. Births and deaths: United States, 1996
63. Mortality from cardiovascular causes among blacks and whites in New York City
64. Mixed life expectancy changes
65. How accurate are hospital discharge data for evaluating effectiveness of care?
66. The validity of hospital administrative data in monitoring variations in breast cancer surgery
67. Ability of Medicare claims data and cancer registries to identify cancer cases and treatment
68. Analysis of a claims database for the identification of patients with carcinoma of breast
69. Border crossing for hospital care and its implications for the use of statewide data
70. Disenrollment of Medicare cancer patients from health maintenance organizations
71. The Medicare-HMO revolving door: The healthy go in and the sick go out
72. The National Cancer Database report on recent hospital cancer program progress toward complete American Joint Committee on Cancer/TNM staging